Functional effects of C-type natriuretic peptide and nitric oxide are attenuated in hypertrophic myocytes from pressure-overloaded mouse hearts

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 3 57-3, 2005, Pages

  Su, Jun ^a   Zhang, Qihang ^a   Moalem, Jacob ^a   Tse, James ^a   Scholz, Peter M ^a   Weiss, Harvey R ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Calcium; Cardiac hypertrophy; Cardiomyocytes; Guanosine 3 ,5 cyclic monophosphate; Guanosine 3 ,5 cyclic monophosphate protein kinase

Indexed keywords

CALCIUM; GUANOSINE PHOSPHATE; GUANYLATE CYCLASE INHIBITOR; GUANYLATE KINASE; N ACETYL S NITROSOPENICILLAMINE; NATRIURETIC PEPTIDE TYPE C; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA STENOSIS; ARTICLE; BIOMECHANICS; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; FEMALE; HEART HYPERTROPHY; HEART MUSCLE CELL; MALE; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SECOND MESSENGER;

ANIMALS; AORTIC VALVE STENOSIS; BLOOD PRESSURE; CARDIOMEGALY; CYCLIC GMP; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, C-TYPE; NITRIC OXIDE; ORGAN SIZE;

EID: 13944259379     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00880.2004     Document Type: Article

References (33)

1. Agullo L, Garcia-Dorado N, Escalona M, Ruiz-Meana J, Inserte, and Soler-Soler J. Effect of ischemia on soluble and particulate guanylyl cyclase-mediated cGMP synthesis in cardiomyocytes. Am J Physiol Heart Circ Physiol 284: H2170-H2176, 2003.
2. 2+-sensitivity of myofibrillar tension in heart failure and its functional implication. Basic Res Cardiol 97, Suppl 1: 1111-1117, 2002.
3. Brutsaert DL. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev 83: 59-115, 2003.
4. Feldman AM, Weinberg EO, Ray PE, and Lorell BH. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res 73: 184-192, 1993.
5. Frey N and Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65: 45-79, 2003.
6. Gong GX, Weiss HR, Tse J, and Scholz PM. Exogenous nitric oxide reduces oxygen consumption of isolated ventricular myocytes less than other forms of guanylate cyclase stimulation. Eur J Pharmacol 344: 299-305, 1998.
7. Hart CY, Hahn EL, Meyer DM, Burnett JC Jr, and Redfield MM. Differential effects of natriuretic peptides and NO on LV function in heart failure and normal dogs. Am J Physiol Heart Circ Physiol 281: H146-H154, 2001.
8. Hirose M, Furukawa Y, Kurogouchi F, Nakajima K, Miyashita Y, and Chiba S. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations. J Pharmacol Exp Ther 286: 70-76, 1998.
9. Holtwick RM, van Eickels BV, Skryabin HA, Baba A, Bubikat F, Begrow Schneider MD, Garbers DL, and Kuhn M. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. J Clin Invest 111: 1399-1407, 2003.
10. Johnatty SE, Dyck JR, Michael LH, Olson EN, and Abdellatif M. Identification of genes regulated during mechanical load-induced cardiac hypertrophy. J Mol Cell Cardiol 32: 805-815, 2000.
11. Kelm M, Feelisch M, Krebber T, Deussen A, Motz W, and Strauer BE. Role of nitric oxide in the regulation of coronary vascular tone in hearts from hypertensive rats. Maintenance of nitric oxide-forming capacity and increased basal production of nitric oxide. Hypertension 25: 186-193, 1995.
12. Leone RJ Jr, Straznicka M, Scholz PM, and Weiss HR. CGMP attenuates cyclic AMP-stimulated inotropy and oxygen consumption in control and hypertrophic hearts. Basic Res Cardiol 95: 28-38, 2000.
13. 2+-ATPase and function of sarcoplasmic reticulum during cardiac hypertrophy. Am J Physiol 261: 23-26, 1991.
14. Lorell BH and Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102: 470-479, 2000.
15. Mazzetti L, Ruocco C, Giovannelli L, Ciuffi M, Franchi-Micheli S, Marra F, Zilletti L, and Failli P. Guanosine 3′: 5′-cyclic monophosphate-dependent pathway alterations in ventricular cardiomyocytes of spontaneously hypertensive rats. Br J Pharmacol 134: 596-602, 2001.
16. Murad F. The nitric oxide-cGMP signal transduction system for intracellular and intercellular communication. Recent Prog Horm Res 49: 239-248, 1994.
17. Nazario B, Hu RM, Pedram A, Prins B, and Levin ER. Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells. J Clin Invest 95: 1151-1157, 1995.
18. Nir A, Zhang DF, Fixler R, Burnett JC Jr, Eilam Y, and Hasin Y. C-type natriuretic peptide has a negative inotropic effect on cardiac myocytes. Eur J Pharmacol 412: 195-201, 2001.
19. Ohte N, Cheng CP, Suzuki M, and Little WC. Effects of atrial natriuretic peptide on left ventricular performance in conscious dogs before and after pacing-induced heart failure. J Pharmacol Exp Ther 291: 589-595, 1999.
20. Pierkes M, Gambaryan S, Boknik P, Lohmann SM, Schmitz W, Potthast R, Holtwick R, and Kuhn M. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice. Cardiovasc Res 53: 852-861, 2002.
21. 2+ sensitivity in airway smooth muscle. J Appl Physiol 92: 257-263, 2002.
22. Rose RA, Lomax AE, Kondo Anand-Srivastava MB, and Giles WR. Effects of C-type natriuretic peptide on ionic currents in mouse sinoatrial node: a role for the NPR-C receptor. Am J Physiol Heart Circ Physiol 286: H1970-H1977, 2004.
23. Rosenkranz AC, Woods RL, Dusting GJ, and Ritchie RH. Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cGMP. Cardiovasc Res 57: 515-522, 2003.
24. Sadoff JD, Scholz PM, Tse J, and Weiss HR. Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3′,5′- monophosphate in left ventricular hypertrophy. J Clin Invest 98: 838-845, 1996.
25. Shah AM and MacCarthy PA. Paracrine and autocrine effects of nitric oxide on myocardial function. Pharmacol Ther 86: 49-86, 2000.
26. Su J, Zhang S, Tse J, Scholz PM, and Weiss HR. Alterations in nitric oxide-cGMP pathway in ventricular myocytes from obese leptin-deficient mice. Am J Physiol Heart Circ Physiol 285: H2111-H2117, 2003.
27. Tajima M, Bartunek J, Weinberg EO, Ito N, and Lorell BH. Atrial natriuretic peptide has different effects on contractility and intracellular pH in normal and hypertrophied myocytes from pressure-overloaded hearts. Circulation 98: 2760-2764, 1998.
28. Tsutsui H, Ishibashi Y, Imanaka-Yoshida K, Yamamoto S, Yoshida T, Sugimachi M, Urabe Y, and Takeshita A. Alterations in sarcoplasmic reticulum calcium-storing proteins in pressure-overload cardiac hypertrophy. Am J Physiol Heart Circ Physiol 272: H168-H175, 1997.
29. 4-induced cardiac hypertrophy. Am J Physiol Heart Circ Physiol 268: H686-H691, 1995.
30. Yan L, Zhang Q, Scholz PM, and Weiss HR. CGMP protein kinase activity is reduced in thyroxine-induced hypertrophic myocytes. Clin Exp Pharmacol Physiol 30: 943-950, 2003.
31. Yanaka N, Kurosawa Y, Minami K, Kawai E, and Omori K. cGMP-phosphodiesterase activity is up-regulated in response to pressure overload of rat ventricles. Biosci Biotechnol Biochem 67: 973-979, 2003.
32. Zhang Q, Molino B, Yan L, Haim T, Vaks Y, Scholz PM, and Weiss HR. Nitric oxide and cGMP protein kinase activity in aged ventricular myocytes. Am J Physiol Heart Circ Physiol 281: H2304-H2309, 2001.
33. 2+ extrusion through localized elevation of cGMP. J Biol Chem 275: 25892-25899, 2000.